Electrosurgery and curettage

[1]

Overview and Definition

Electrosurgery is the controlled application of high-frequency alternating current to living tissue so that resistive (Joule) heating produces predictable thermal effects: superficial dehydration (electrodesiccation), non-contact surface charring (electrofulguration), deeper vessel sealing (electrocoagulation), or vaporising incision (electrosection).[1][3] In dermatology the workhorse office device is often a hyfrecator — a monoterminal high-voltage, low-amperage unit optimised for desiccation and fulguration of small lesions.

Electrocautery is a related but distinct concept: a metal tip is heated by current within the instrument, and the hot tip is applied to tissue. No electrical circuit runs through the patient. Examiners reward candidates who refuse to use the words interchangeably.[1]

Curettage is mechanical scraping with a ring or spoon curette (commonly Fox curettes). Soft, friable epidermis and tumour nests shear preferentially from the tougher dermal collagen plane — the physical principle that underpins curettage and electrodesiccation (C&E / ED&C) for low-risk basal cell carcinoma.[8]

Classification of Modalities

Monoterminal circuits use a single active electrode; the patient body provides capacitive return to earth. Biterminal circuits add a large dispersive (return) pad so current path and heating are more controllable and deeper coagulation is efficient.[1][2]

Epidemiology and Practice Context

Office electrosurgery is among the most frequently performed destructive procedures in dermatology and primary-care skin clinics worldwide. Volume is driven by skin tags, seborrhoeic keratoses, cherry angiomas, viral warts, and — in systems that still emphasise it — low-risk BCC treated with C&E.[3][8] In skin-of-colour populations the cosmetic stakes of dyspigmentation and keloid are higher; counselling must be explicit even for “minor” energy procedures.

Pathophysiology and Mechanism

High-frequency current oscillates tissue water and ions; electrical energy converts to heat. At lower thermal doses proteins denature and cells dehydrate; at higher doses vessels coagulate and tissue carbonises.[1] Depth and width of injury depend on waveform, power setting, electrode size, contact time, and tissue impedance — settings are device-specific and not transferable as raw numbers between brands.[2]

Curettage works because many basaloid tumours are cohesive enough to feel gritty yet softer than reticular dermis. The operator scrapes until a firm, “squeaky” dermal base is reached, then electrodesiccates residual microscopic nests at the base and rim. One to three cycles extend the treated field laterally and in depth for selected low-risk tumours.[8][9]

Clinical Indications

Benign destructive uses

• Pedunculated skin tags (acrochordons): tent and desiccate base, or snip then desiccate stalk base for haemostasis.
• Seborrhoeic keratoses, small warts, molluscum (selected), cherry angiomas, milia after nick-and-express.

Premalignant and malignant (selected only)

• Low-risk BCC: primary, well-defined, non-aggressive histology, typically less than 2 cm, trunk or extremities, non-terminal hair-bearing high-risk sites preferred for surgery instead.[7][8]
• Selected SCC in situ / Bowen disease on low-risk sites when surgery is declined or unsuitable — with clear consent about recurrence and follow-up.

Haemostasis adjunct

After snip, shave, punch, or elliptical excision, brief electrocoagulation or desiccation seals pinpoint bleeders without replacing meticulous suture technique for larger vessels.

Differential: When Not to Choose Electrosurgery

European interdisciplinary BCC guidance places surgery (including Mohs where indicated) at the centre of care and limits destructive options to carefully selected low-risk disease.[7]

Bedside Assessment and Consent

Before energy:

1. Confirm diagnosis clinically and dermoscopically; biopsy if uncertain.
2. Risk-stratify NMSC (size, site, borders, primary vs recurrent, subtype, immunosuppression).
3. Screen for pacemaker, ICD, cochlear implant, and other implantable electronic devices.[4][5]
4. Note phototype, keloid tendency, anticoagulation, and site tension lines.
5. Consent for scar, pigment change, infection, incomplete clearance, recurrence, need for further treatment, and device/fire precautions.

Investigations and Specimen Reality

Curettings can be submitted for histologic confirmation, but they are fragmented and cannot provide a complete margin assessment comparable to an orientated excision. Pure hyfrecation of a tag without capture yields no specimen. If the clinical question is “is this cancer and is it clear?”, choose a biopsy or excision pathway, not C&E alone.[8]

Management — Technique

General electrosurgery sequence

1. Position, light, smoke evacuation if available.[10]
2. Cleanse; alcohol-based prep must be completely dry before any spark.[2]
3. Local anaesthetic (typically lidocaine 1% ± adrenaline) and full latency.
4. Lowest effective power; brief contact; reassess continuously.
5. Haemostasis, petroleum-based ointment or non-stick dressing, aftercare card.

C&E for low-risk BCC (classic teaching sequence)

1. Anaesthetise and stretch the field.
2. Curette the soft tumour firmly until a firm dermal base is felt; extend a few millimetres beyond visible tumour.
3. Electrodesiccate the base and a rim of surrounding epidermis.
4. Repeat curettage of charred soft tissue and re-desiccate — typically 1–3 cycles depending on thickness and training tradition.[8]
5. Dress; counsel 2–6 week healing depending on size and site; arrange surveillance.

Randomised data comparing curettage with cryosurgery for superficial BCC underscore that operator technique and selection, not brand of destruction alone, drive outcomes.[9]

Haemostasis after excision

Use pinpoint coagulation; avoid wide charring of wound edges that impairs healing and widens scar. Large vessels are better ligated or under-sewn than “cooked.”

Device Safety and Special Scenarios

Implantable electronic devices (CIEDs)

Electrosurgery can cause electromagnetic interference, inhibition, or rarely reprogramming. Practical mitigations used by dermatologic surgeons include: prefer bipolar when coagulation is needed; use short intermittent bursts; keep the active electrode and any return path away from the generator and leads; avoid cutting current when possible; continuous monitoring / magnet protocols per cardiology advice in high-risk cases.[4][5] Even hyfrecation is not universally interference-free; published work documents potential interaction and supports a safety-first office protocol.[6]

Fire and oxygen

Sparks ignite alcohol vapour and oxygen-enriched atmospheres. Dry prep fully; never drape a pool of alcohol; be cautious near nasal oxygen.

Surgical plume

Different electrosurgical techniques generate variable plume; use suction/evacuation and PPE — plume may carry particulates and bioaerosols.[10]

Complications

[1] [1]

Special Populations

• Children: brief procedures; pain and consent dominate; cotton-tip cryotherapy is often kinder for molluscum than aggressive hyfrecation.
• Pregnancy: lidocaine local anaesthesia for small procedures is widely used when treatment cannot wait; avoid non-essential energy near monitoring equipment.
• Skin of colour: counsel permanent hypopigmentation and keloid risk; choose alternatives on cosmetically critical sites when possible.
• Immunosuppressed: higher NMSC burden and recurrence — bias toward margin-controlled surgery for anything beyond clearly low-risk lesions.[7]

Prognosis and Follow-Up

Benign hyfrecation sites usually re-epithelialise within days to a few weeks. C&E wounds heal by secondary intention under eschar. For low-risk BCC treated with C&E, structured skin checks and a low threshold to re-biopsy any persistent papule are mandatory; poor selection predicts recurrence more than “bad luck.”[7][8]

Evidence, Guidelines, and Regional Practice

JAAD two-part electrosurgery reviews remain the clearest fellowship-level physics and safety backbone.[1][2] Contemporary dermatologic summaries reiterate modality choice and office workflows.[3] European BCC consensus prioritises surgery and restricts destructive modalities to selected low-risk disease.[7] US practice historically used C&E more liberally for low-risk trunk/extremity BCC; UK/ANZ training more often defaults to excision when practical. CIED precautions rest on device literature and surgeon survey practice patterns rather than large RCTs.[4][5][6]

Exam Pearls

• Electrosurgery = current through tissue; electrocautery = hot wire, no patient circuit.
• Four modalities: desiccation, fulguration, coagulation, section.
• C&E: soft tumour → firm dermis → desiccate base/rim → 1–3 cycles for low-risk NMSC only.
• Never destroy melanoma-suspect lesions.
• Dry alcohol; CIED history every time; plume control when available. [1]

Red Flags

Exam application bank (NEET-PG / INICET)

One-line answer

Electrosurgery uses high-frequency alternating current to desiccate, fulgurate, coagulate, or cut skin. Curettage shears friable tumour from firm dermis. Combined electrodesiccation and curettage (ED&C/C&E) is a first-line destructive option only for carefully selected low-risk non-melanoma skin cancer and common benign lesions. Never destroy suspected melanoma. Dry alcohol prep fully; mitigate pacemaker/ICD interference.

Worked stems (answer without another resource)

Stem 1 — Classic presentation. Map symptoms to mechanism; name the first investigation and first treatment step with dose/route if drug therapy is standard. [1]

Stem 2 — Unstable / complicated. List red flags that force immediate resuscitation, theatre, ICU, antidote, or reperfusion — and what you do in the first 15 minutes. [1]

Stem 3 — Atypical group. Elderly, pregnancy, child, or immunocompromised: how presentation and thresholds change. [1]

Stem 4 — Differential trap. Name the three closest mimics and one discriminator for each. [1]

Stem 5 — Disposition. Who goes home with safety-netting, who is admitted, who needs HDU/ICU/theatre, and what follow-up is mandatory. [1]

Rapid viva checklist

1. Definition + classification
2. Pathophysiology chain
3. Bedside signs / criteria
4. Score with exact components (if any)
5. Emergency bundle
6. Definitive therapy with doses
7. Complications of disease and of treatment
8. Special populations
9. Guideline/trial name if classic
10. Three exam traps

Coverage self-check

If you cannot answer any stem above from this page alone, re-read the matching section — the page is intended to be self-sufficient for final-prof and NEET-PG/INICET questions on Electrosurgery and curettage.

Expanded exam teaching (depth pass)

Clinical reasoning

For Electrosurgery and curettage, examiners test whether you can prioritise life threats, choose the right first test, and give specific therapy (agent, dose, route, timing). Generic phrases without numbers score poorly.

Mechanism → feature map

Build a short chain: cause → pathophysiologic intermediate → clinical feature → complication. Every major symptom in the classic vignette should sit on that chain.

Investigation strategy

• Bedside/first-line tests that change immediate management
• Confirmatory or staging tests
• What a normal result does not exclude
• When not to delay treatment for imaging (unstable patient)

Management ladder

1. Resuscitation / ABC / sepsis or haemorrhage bundle as relevant
2. Specific antidote / procedure / antimicrobial / reperfusion / surgery
3. Supportive care and monitoring targets
4. Definitive long-term therapy and secondary prevention
5. Disposition and safety-net advice

Special populations

Always prepare one line each for children, pregnancy, elderly, renal/hepatic impairment, and immunocompromised patients when the topic allows.

Pitfalls that fail candidates

• Treating the number not the patient
• Missing pregnancy status when relevant
• Imaging before stabilisation
• Wrong empiric cover or wrong antidote timing
• Incomplete counselling on recurrence, adherence, or red-flag return

Electrosurgery uses high-frequency alternating current to desiccate, fulgurate, coagulate, or cut skin. Curettage shears friable tumour from firm dermis. Combined electrodesiccation and curettage (ED&C/C&E) is a first-line destructive option only for carefully selected low-risk non-melanoma skin cancer and common benign lesions. Never destroy suspected melanoma. Dry alcohol prep fully; mitigate pacemaker/ICD interference. [1]

Structured revision sheet

Must-know numbers and names

List every score, size threshold, dose, and time window from this topic on a blank page from memory, then check against the sections above.

Three classic MCQ angles

1. Most likely diagnosis given a vignette
2. Next best step in management
3. Most appropriate investigation

Three classic SAQ angles

1. Pathophysiology in five steps
2. Management algorithm with doses
3. Complications and prevention

Clinical station flow

Greet → focused history → targeted exam → investigations → explain diagnosis → emergency care → definitive plan → safety-net / follow-up → answer examiner questions on mechanism and pitfalls.

[1]

• High-risk site/histology BCC managed with C&E alone.
• Sparking wet alcohol or free-flow oxygen.
• Ignoring pacemaker/ICD.
• Promising “clear margins” from curettings without orientated excision. [1]

[1] [1] [1]

References

1. [1]Taheri A, Mansoori P, Sandoval LF, et al. Electrosurgery: part I. Basics and principles J Am Acad Dermatol, 2014.PMID 24629361
2. [2]Taheri A, Mansoori P, Sandoval LF, et al. Electrosurgery: part II. Technology, applications, and safety of electrosurgical devices J Am Acad Dermatol, 2014.PMID 24629362
3. [3]Eginli A, Haidari W, Farhangian M, et al. Electrosurgery in dermatology Clin Dermatol, 2021.PMID 34809763
4. [4]Voutsalath MA, Bichakjian CK, Pelosi F, et al. Electrosurgery and implantable electronic devices: review and implications for office-based procedures Dermatol Surg, 2011.PMID 21585593
5. [5]Cervantes JA, Fox MC, Jambusaria-Pahlajani A. Electrosurgery and Implantable Devices: A Survey of Dermatologic Surgeons Dermatol Surg, 2021.PMID 33165061
6. [6]Amin SD, Homan KB, Assar M, et al. Hyfrecation and Interference With Implantable Cardiac Devices Dermatol Surg, 2020.PMID 31652225
7. [7]Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines Eur J Cancer, 2019.PMID 31288208
8. [8]Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management Yale J Biol Med, 2015.PMID 26029015
9. [9]Backman EJ, Polesie S, Berglund S, et al. Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial J Eur Acad Dermatol Venereol, 2022.PMID 35543079
10. [10]Riopelle AM, Potter CT, Jeong D, et al. Plume Generated by Different Electrosurgical Techniques: An In Vitro Experiment on Human Skin Dermatol Surg, 2022.PMID 36054048